MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
803.28
-7.03
-0.87%
Opening 14:38 09/09 EDT
OPEN
803.83
PREV CLOSE
810.31
HIGH
808.63
LOW
796.73
VOLUME
270.15K
TURNOVER
--
52 WEEK HIGH
859.34
52 WEEK LOW
538.24
MARKET CAP
82.70B
P/E (TTM)
19.86
1D
5D
1M
3M
1Y
5Y
1D
Sanofi, Regeneron Could Extend Dupixent Patent -- Market Talk
Dow Jones · 7h ago
Astra, Roche win new Outperform ratings as RBC initiates EU pharma coverage
Seeking Alpha · 7h ago
Did Libtayo Recall Just Shift Regeneron's (REGN) Investment Narrative?
Simply Wall St · 1d ago
Michael Burry Remains Bullish on Veeva but Trimmed His Position. What This Means for VEEV Stock.
Barchart · 2d ago
Weekly Report: what happened at REGN last week (0831-0904)?
Weekly Report · 2d ago
How Is Moderna's Stock Performance Compared to Other Healthcare Stocks
Barchart · 2d ago
Notable healthcare headlines for the week: UnitedHealth, Moderna, and Medtronic in focus
Seeking Alpha · 3d ago
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
The Motley Fool · 5d ago
More
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Lynozyfic, and others.

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.